|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/57 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 25/00 | (2006.01) |
| (11) | Number of the document | 3157548 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15741128.1 |
| Date of filing the European patent application | 2015-06-18 | |
| (97) | Date of publication of the European application | 2017-04-26 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/063760 |
| Date | 2015-06-18 |
| (87) | Number | WO 2015/193457 |
| Date | 2015-12-23 |
| (30) | Number | Date | Country code |
| 14172910 | 2014-06-18 | EP |
| (72) |
KLEINSCHNITZ, Christoph , DE
NOLTE, Marc , DE
SIRÉN, Anna-Leena , DE
ALBERT-WEISSENBERGER, Christiane , DE
HOPP-KRAEMER, Sarah , DE
|
| (73) |
CSL Behring GmbH ,
Emil-von-Behring-Strasse 76, 35041 Marburg,
DE
|
| (54) | THERAPY USING A FACTOR XII INHIBITOR IN A NEUROTRAUMATIC DISORDER |
| THERAPY USING A FACTOR XII INHIBITOR IN A NEUROTRAUMATIC DISORDER |